Back to Search Start Over

The transcription factor c-Myb regulates CD8 + T cell stemness and antitumor immunity.

Authors :
Gautam S
Fioravanti J
Zhu W
Le Gall JB
Brohawn P
Lacey NE
Hu J
Hocker JD
Hawk NV
Kapoor V
Telford WG
Gurusamy D
Yu Z
Bhandoola A
Xue HH
Roychoudhuri R
Higgs BW
Restifo NP
Bender TP
Ji Y
Gattinoni L
Source :
Nature immunology [Nat Immunol] 2019 Mar; Vol. 20 (3), pp. 337-349. Date of Electronic Publication: 2019 Feb 18.
Publication Year :
2019

Abstract

Stem cells are maintained by transcriptional programs that promote self-renewal and repress differentiation. Here, we found that the transcription factor c-Myb was essential for generating and maintaining stem cells in the CD8 <superscript>+</superscript> T cell memory compartment. Following viral infection, CD8 <superscript>+</superscript> T cells lacking Myb underwent terminal differentiation and generated fewer stem cell-like central memory cells than did Myb-sufficient T cells. c-Myb acted both as a transcriptional activator of Tcf7 (which encodes the transcription factor Tcf1) to enhance memory development and as a repressor of Zeb2 (which encodes the transcription factor Zeb2) to hinder effector differentiation. Domain-mutagenesis experiments revealed that the transactivation domain of c-Myb was necessary for restraining differentiation, whereas its negative regulatory domain was critical for cell survival. Myb overexpression enhanced CD8 <superscript>+</superscript> T cell memory formation, polyfunctionality and recall responses that promoted curative antitumor immunity after adoptive transfer. These findings identify c-Myb as a pivotal regulator of CD8 <superscript>+</superscript> T cell stemness and highlight its therapeutic potential.

Details

Language :
English
ISSN :
1529-2916
Volume :
20
Issue :
3
Database :
MEDLINE
Journal :
Nature immunology
Publication Type :
Report
Accession number :
30778251
Full Text :
https://doi.org/10.1038/s41590-018-0311-z